Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours
AUTOR(ES)
Hussein, D
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2713707Documentos Relacionados
- Flagellar-phase variation: isolation of the rh1 gene.
- Lack of the Rhesus protein Rh1 impairs growth of the green alga Chlamydomonas reinhardtii at high CO2
- Preclinical Assessment of the Efficacy of Mycograb, a Human Recombinant Antibody against Fungal HSP90
- Parallelism of amino acid changes at the RH1 affecting spectral sensitivity among deep-water cichlids from Lakes Tanganyika and Malawi
- Efficacy of azithromycin as a causal prophylactic agent against murine malaria.